Explore provider case studies on generic medications, from seamless switches in statins to the risks of breakthrough seizures in AEDs and FDA bioequivalence standards.
Read moreExplore how the FDA Orange Book lists approved generic drugs, covering therapeutic equivalence codes, patent listings, and the ANDA process for market entry.
Read moreGenerics save money but aren't always interchangeable. Pharmacists must watch for therapeutic failures, especially with narrow therapeutic index drugs like levothyroxine and warfarin. Learn when to flag unsafe generics and how to protect patients.
Read more